|
Tetra is committed to building a leading portfolio of clinical trial stage treatments, based on phosphodiesterase sub-type inhibitors for both neuroscience and non-neuroscience disorders. These are fields in which we believe Tetra is poised to deliver multiple novel treatments, with the potential to change patients’ lives.
SOCIAL MEDIA:
Website: http://tetradiscovery.com/
Facebook: https://www.facebook.com/tetradiscovery/
Twitter: https://twitter.com/TetradDiscovery
LOCATION:
38 Fulton St W Ste 303 Grand Rapids, MI 49503
PEOPLE:
CEO: Dr. Mike E. Gurney PHD, MBA
VP: Mr. Richard M. Erwin |
